🇺🇸 FDA
Patent

US 9618514

Methods of evaluating patients using E-cadherin and vimentin

granted A61KA61K31/433A61K38/50

Quick answer

US patent 9618514 (Methods of evaluating patients using E-cadherin and vimentin) held by Agios Pharmaceuticals, Inc. expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K31/433, A61K38/50